IL122733A - Pharmaceutical compositions for use in the treatment of allergic asthma - Google Patents

Pharmaceutical compositions for use in the treatment of allergic asthma

Info

Publication number: IL122733A
Authority: IL; Israel
Prior art keywords: ige; dose; antagonist; antibody; maintenance dose
Prior art date: 1995-07-27

Application number

IL12273396A

Other languages

English (en)

Other versions

IL122733A0 (en

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-27

Filing date

1996-07-24

Publication date

2001-09-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL122733(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-07-24 Application filed by Genentech Inc filed Critical Genentech Inc

1998-08-16 Publication of IL122733A0 publication Critical patent/IL122733A0/xx

2001-09-13 Publication of IL122733A publication Critical patent/IL122733A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Mycology (AREA)
Rheumatology (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL12273396A 1995-07-27 1996-07-24 Pharmaceutical compositions for use in the treatment of allergic asthma IL122733A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US50801495A	1995-07-27	1995-07-27
PCT/US1996/012275 WO1997004807A1 (en)	1995-07-27	1996-07-24	Methods for treatment of allergic asthma

Publications (2)

Publication Number	Publication Date
IL122733A0 IL122733A0 (en)	1998-08-16
IL122733A true IL122733A (en)	2001-09-13

Family

ID=24021032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12273396A IL122733A (en)	1995-07-27	1996-07-24	Pharmaceutical compositions for use in the treatment of allergic asthma

Country Status (16)

Country	Link
EP (1)	EP0841946B2 (es)
JP (1)	JP4153560B2 (es)
CN (2)	CN101172100A (es)
AR (1)	AR003468A1 (es)
AT (1)	ATE225185T1 (es)
AU (1)	AU715338B2 (es)
CA (1)	CA2226624C (es)
DE (1)	DE69624116T3 (es)
DK (1)	DK0841946T4 (es)
ES (1)	ES2186796T5 (es)
IL (1)	IL122733A (es)
MX (1)	MX9800760A (es)
PT (1)	PT841946E (es)
RU (1)	RU2229288C2 (es)
WO (1)	WO1997004807A1 (es)
ZA (2)	ZA966075B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6267958B1 (en)	1995-07-27	2001-07-31	Genentech, Inc.	Protein formulation
US6171586B1 (en)	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
US6991790B1 (en)	1997-06-13	2006-01-31	Genentech, Inc.	Antibody formulation
WO1999045777A1 (en) *	1998-03-10	1999-09-16	The Children's Hospital Of Philadelphia	Compositions and methods for treatment of asthma
US6299875B1 (en) *	1998-06-04	2001-10-09	Panacea Pharmaceuticals, Llc	Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en)	1998-11-02	2005-07-05	Resistentia Pharmaceuticals Ab	Immunogenic polypeptides for inducing anti-self IgE responses
US8703126B2 (en)	2000-10-12	2014-04-22	Genentech, Inc.	Reduced-viscosity concentrated protein formulations
SI1324776T2 (en) *	2000-10-12	2018-06-29	Genentech, Inc.	Concentrated protein formulations with reduced viscosity
BRPI0316092B8 (pt)	2002-11-08	2021-05-25	Ablynx Nv	anticorpos de domínio único direcionados contra o fator de necrose tumoral alfa e usos para os mesmos
MXPA05004955A (es)	2002-11-08	2005-11-17	Ablynx Nv	Anticuerpos de region unica dirigidos contra el factor-alfa de necrosis de tumor y usos de estos.
JO3000B1 (ar)	2004-10-20	2016-09-05	Genentech Inc	مركبات أجسام مضادة .
DE202006020194U1 (de) *	2006-03-01	2007-12-06	Bioceuticals Arzneimittel Ag	G-CSF-Flüssigformulierung
US20100311604A1 (en) *	2007-01-29	2010-12-09	Valtion Teknillinen Tutkimuskeskus	Method for producing novel ige based reagents
AR065368A1 (es)	2007-02-15	2009-06-03	Astrazeneca Ab	Anticuerpos para moleculas de ige
EP2052736A1 (en) *	2007-10-26	2009-04-29	Nycomed Danmark ApS	Parathyroid hormone formulations und uses thereof
CN105126099A (zh) *	2007-12-21	2015-12-09	弗·哈夫曼-拉罗切有限公司	抗体制剂
CN101903030A (zh) *	2007-12-21	2010-12-01	灵感生物制药学有限公司	含海藻糖的稳定化因子ix制剂
AR073997A1 (es) *	2008-10-29	2010-12-15	Wyeth Corp	Formulaciones de moleculas de union a antigeno de dominio unico. metodo. kit
JP6113404B2 (ja)	2008-10-29	2017-04-12	アブリンクスエン．ヴェー．	単一ドメイン抗原結合分子の精製方法
HUE038405T2 (hu)	2009-12-15	2018-10-29	Ascendis Pharma Endocrinology Div A/S	Átmenetileg polimer hordozóhoz kapcsolt száraz növekedési hormon készítmény
EP4450523A2 (en)	2010-04-02	2024-10-23	Amunix Pharmaceuticals, Inc.	Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
CN102533704A (zh) *	2010-12-30	2012-07-04	上海雅心生物技术有限公司	即配即用型的胰蛋白酶制剂
PL2691112T3 (pl) *	2011-03-31	2018-09-28	Merck Sharp & Dohme Corp.	Stabilne preparaty przeciwciał przeciw ludzkiemu receptorowi programowanej śmierci pd-1 i terapie powiązane
US20140302021A1 (en) *	2011-10-25	2014-10-09	Onclave Therapeutics Limited	Antibody formulations and methods
BR112016006455A2 (pt) *	2013-09-27	2017-08-01	Hanmi Pharm Ind Co Ltd	?formulação de conjugado de hormônio de crescimento humano de ação prolongada?
CN104707146B (zh) *	2013-12-16	2019-04-16	浙江海正药业股份有限公司	一种含有阿达木单抗的药物组合物
EP3653227B9 (en)	2014-11-18	2023-03-08	Ascendis Pharma Endocrinology Division A/S	Novel polymeric hgh prodrugs
WO2016079302A1 (en)	2014-11-21	2016-05-26	Ascendis Pharma Growth Disorders Division A/S	Long-acting growth hormone dosage forms
GB201610198D0 (en)	2016-06-10	2016-07-27	Ucb Biopharma Sprl	Anti-ige antibodies
CN110913906A (zh)	2017-05-02	2020-03-24	默沙东公司	抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂
JOP20190260A1 (ar)	2017-05-02	2019-10-31	Merck Sharp & Dohme	صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
UA125971C2 (uk)	2017-07-25	2022-07-20	Джянгсу Хенгруй Медісін Ко., Лтд.	Фармацевтична композиція, яка містить протеїновий комплекс il-15, та її застосування
CR20200394A (es) *	2018-02-09	2020-11-05	Genentech Inc	Métodos terapéuticos y diagnósticos para enfermedades inflrmatorias mediadas por mostocitos
CN110732023B (zh) *	2018-07-18	2023-06-16	江苏恒瑞医药股份有限公司	一种her2抗体药物组合物及其用途
BR112023000400A2 (pt)	2020-07-10	2023-03-21	Shanghai Jemincare Pharmaceutical Co Ltd	Anticorpo anti-ige engenheirado e aplicação do mesmo
TW202409078A (zh) *	2022-07-18	2024-03-01	中國大陸商蘇州創勝醫藥集團有限公司	穩定之包含抗gremlin1抗體的藥物製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) *	1987-11-20	1991-11-14	Kissei Pharmaceutical Co. Ltd.	4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3853636T3 (de) *	1987-12-31	1999-04-08	Tanox Biosystems, Inc., Houston, Tex.	Antigene epitope, die sich ausschliesslich auf ige-tragenden b-lymphocyten befinden.
AU3923293A (en) *	1992-03-20	1993-10-21	Immunet	Human monoclonal antibodies and methods for human monoclonal antibody production
JPH07118168A (ja) *	1993-10-19	1995-05-09	Tomoyasu Ra	ＩｇＥ産生抑制剤
DE69333484T2 (de) *	1992-09-24	2005-03-24	Novartis Ag	Umgestaltete monoklonale Antikörper gegen ein Immunglobulinisotyp
DE4344824C1 (de) *	1993-12-28	1995-08-31	Immuno Ag	Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

1996
- 1996-07-17 ZA ZA9606075A patent/ZA966075B/xx unknown
- 1996-07-23 ZA ZA9606240A patent/ZA966240B/xx unknown
- 1996-07-23 CN CNA2007101928120A patent/CN101172100A/zh active Pending
- 1996-07-23 RU RU98103237/15A patent/RU2229288C2/ru not_active IP Right Cessation
- 1996-07-23 CN CN2007101928065A patent/CN101172099B/zh not_active Expired - Lifetime
- 1996-07-24 EP EP96926134A patent/EP0841946B2/en not_active Expired - Lifetime
- 1996-07-24 AT AT96926134T patent/ATE225185T1/de active
- 1996-07-24 MX MX9800760A patent/MX9800760A/es active IP Right Grant
- 1996-07-24 ES ES96926134T patent/ES2186796T5/es not_active Expired - Lifetime
- 1996-07-24 WO PCT/US1996/012275 patent/WO1997004807A1/en active IP Right Grant
- 1996-07-24 PT PT96926134T patent/PT841946E/pt unknown
- 1996-07-24 DK DK96926134T patent/DK0841946T4/da active
- 1996-07-24 AU AU66381/96A patent/AU715338B2/en not_active Expired
- 1996-07-24 JP JP50775897A patent/JP4153560B2/ja not_active Expired - Lifetime
- 1996-07-24 IL IL12273396A patent/IL122733A/en not_active IP Right Cessation
- 1996-07-24 DE DE69624116T patent/DE69624116T3/de not_active Expired - Lifetime
- 1996-07-24 CA CA2226624A patent/CA2226624C/en not_active Expired - Lifetime
- 1996-07-25 AR ARP960103741A patent/AR003468A1/es unknown

Also Published As

Publication number	Publication date
CN101172099B (zh)	2012-02-15
DE69624116D1 (de)	2002-11-07
ES2186796T3 (es)	2003-05-16
EP0841946B1 (en)	2002-10-02
MX9800760A (es)	1998-04-30
ZA966075B (en)	1998-01-19
AU6638196A (en)	1997-02-26
DE69624116T3 (de)	2009-07-09
DK0841946T3 (da)	2003-02-10
CN101172099A (zh)	2008-05-07
JPH11510172A (ja)	1999-09-07
DK0841946T4 (da)	2009-02-16
ZA966240B (en)	1998-01-23
CA2226624C (en)	2013-07-16
AR003468A1 (es)	1998-08-05
JP4153560B2 (ja)	2008-09-24
AU715338B2 (en)	2000-01-20
RU2229288C2 (ru)	2004-05-27
EP0841946A1 (en)	1998-05-20
IL122733A0 (en)	1998-08-16
ES2186796T5 (es)	2009-04-01
WO1997004807A1 (en)	1997-02-13
CA2226624A1 (en)	1997-02-13
ATE225185T1 (de)	2002-10-15
CN101172100A (zh)	2008-05-07
DE69624116T2 (de)	2003-06-18
EP0841946B2 (en)	2008-10-15
PT841946E (pt)	2003-02-28

Publication	Publication Date	Title
EP0841946B1 (en)	2002-10-02	Methods for treatment of allergic asthma
US20070020256A1 (en)	2007-01-25	Methods for treatment of allergic asthma
MXPA98000760A (es)	1998-04-01	Metodos para el tratamiento del asma alergica
EP0739214B1 (en)	1998-03-18	A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
DE69637131T2 (de)	2008-02-07	Humanisierte antikörper gegen humanes gp39, zusammensetzungen die diese enthalten und deren therapeutische verwendungen
JP2002518347A (ja)	2002-06-25	前立腺癌治療のための免疫療法組成物および方法
US11518801B1 (en)	2022-12-06	Methods and compositions for treating diabetes and diabetic complications
AU756677B2 (en)	2003-01-23	Anti-TNFalpha antibodies in therapy of asthma
CN104684929A (zh)	2015-06-03	治疗血管疾病及其并发症
CN107614530A (zh)	2018-01-19	用于多发性骨髓瘤（mm）的治疗
CN111886252A (zh)	2020-11-03	促进胰岛细胞生长的方法
JP2840131B2 (ja)	1998-12-24	液性免疫の持続性抑制方法
US9587034B2 (en)	2017-03-07	Anti-mIgE antibodies that bind to the junction between CH4 and CεmX domains
AT503297B1 (de)	2007-09-15	Allergen-spezifische antikörper
WO1997010004A1 (en)	1997-03-20	Methods for treatment of interstitial cystitis
Fick	2002	IgE and anti-IgE therapy in asthma and allergic disease
Hannestad et al.	1992	Anti‐idiotypic immune responses against adjuvant‐free isologous IgM monoclonal antibodies and their augmentation by complex formation between IgM and albumin in bovine serum
AU2022225026A1 (en)	2023-09-14	Preparation of siglec-15 binding protein and use thereof
JP2002540078A (ja)	2002-11-26	Ｌｆａ−１アンタゴニスト投与量の増加によるｌｆａ−１関連疾患の治療
RO116809B1 (ro)	2001-06-29	Anticorp recombinant, monoclonal, compozitie farmaceutica si metoda de tratament cu aceasta

Legal Events

Date	Code	Title
2002-09-12	KB	Patent renewed
2006-09-05	KB	Patent renewed
2010-11-30	KB	Patent renewed
2014-08-31	KB	Patent renewed
2017-02-28	EXP	Patent expired